Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
EPIGENETIC MECHANISMS IMPARTING DRUG RESISTANCE IN BREAST CANCER Recent findings have highlighted the significance of epigenetic alterations in developing and sustaining drug resistance in breast carcinoma, offering new avenues for therapeutic intervention [45]
Short-acting formulations such as exenatide (Byetta) and lixisenatide (Lyxumia) have half-lives of approximately 24 hours
Let's push boundaries together
Whitehead KA, Dorkin JR, Vegas AJ, Chang PH, Veiseh O, Matthews J, et al
US$ 22.73
.png)
US$ 21.14
US$ 23.77
US$ 23.16
US$ 20.89
US$ 27.18
US$ 24.00
